JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,530,000 | +4.6% | 120,988 | +2.6% | 2.47% | +10.8% |
| Q3 2017 | $5,289,000 | +49.9% | 117,896 | -0.1% | 2.23% | +53.2% |
| Q2 2017 | $3,528,000 | +34.9% | 118,024 | +0.1% | 1.45% | +34.6% |
| Q1 2017 | $2,616,000 | +17.7% | 117,896 | 0.0% | 1.08% | +14.9% |
| Q4 2016 | $2,222,000 | -37.2% | 117,896 | 0.0% | 0.94% | -43.0% |
| Q3 2016 | $3,538,000 | -28.3% | 117,896 | +3.1% | 1.65% | -37.3% |
| Q2 2016 | $4,937,000 | +13.3% | 114,396 | 0.0% | 2.63% | +8.9% |
| Q1 2016 | $4,357,000 | -54.7% | 114,396 | -47.8% | 2.42% | -17.6% |
| Q4 2015 | $9,626,000 | – | 218,942 | – | 2.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |